The same dose of Ozempic can produce dramatically different results depending on why a person reaches for food. A year-long study in Japan found that people who overeat because food looks or smells irresistible lost more weight and improved blood sugar more than those who eat to cope with stress or sadness.
The eating habit that predicts success
Researchers at Kyoto University followed 92 people with type 2 diabetes in Gifu Prefecture during their first year on GLP-1 receptor agonists. They measured body weight, blood glucose, cholesterol, and eating behaviors at the start, after three months, and after one year. The key difference came down to two types of overeating: external eating and emotional eating.
External eaters tend to eat because tempting food catches their attention, not because they are hungry. Emotional eaters eat to manage negative feelings. The study showed that external eaters got far more benefit from the drugs over the full year. Emotional eaters did not see the same long term improvements.
Why local doctors are paying attention
Japan has a high rate of type 2 diabetes, and GLP-1 drugs like Ozempic are widely prescribed. But doctors have noticed that some patients respond well while others do not. This study offers a possible explanation. Professor Daisuke Yabe, senior author of the article in Frontiers in Clinical Diabetes and Healthcare, said that assessing a patient's eating behavior before treatment could help predict who will benefit most.
The findings suggest that GLP-1 drugs work best for people whose overeating is triggered by external cues like the sight or smell of food. For people whose eating is driven by emotions, the drugs may be less effective.
A simple questionnaire could change treatment
The study used standard questionnaires to sort participants into eating behavior types. This kind of assessment is quick and inexpensive. If doctors can identify which patients are likely to respond well, they could set more realistic expectations and consider alternative strategies for emotional eaters.
The research did not test whether emotional eaters might benefit from combining GLP-1 drugs with counseling or other support. That remains an open question. But the study makes clear that one drug does not fit all, and the reason people overeat matters as much as the drug itself.
